However, while changes in AFP may correlate with other measures of tumour assessment, neither changes in AFP nor other objective measures of tumour response have been good surrogates to predict OS.27 In REACH, while an AFP response was associated with significantly longer OS, analyses support that OS benefit extends to a larger population. This evidence concerns the gene AFP and neoplasm.